Skip to main content

Advertisement

Figure 2 | BMC Cancer

Figure 2

From: Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer

Figure 2

Overall survival of 68 pancreatic cancer patients in relation with B7-H3 protein expression. Patients with high tumor B7-H3 protein expression had a significantly better prognosis than patients without or with low tumor B7-H3 protein expression (p = 0.0067). The median survival of patients with high tumor B7-H3 protein expression was 17.8 months in contrast to 11.0 months in patients without or with low tumor B7-H3 protein expression.

Back to article page